About Adamed
About Adamed
Adamed in Poland
Adamed across the globe
Management Team of Adamed Pharma S.A.
Mission and values
Ethics and Compliance
Adamed for the Family
News
Adamed is a pharmaceutical and biotechnology company with almost 40 years of experience, founded on the basis of Polish scientific advances and a patent portfolio.
Products
Produkty
Prescription drugs
OTC drugs
Dietary supplements
Dermocosmetics
Medical devices
We provide patients with the highest quality medicinal products that are a response to chronic civilization diseases in several therapeutic areas.
Development and innovation
Development and innovation
Research
Development of proprietary medicines
Development of value-added medicines
Business development Startups Requests for proposals and tenders
Innovation is at the core of Adamed’s evolution. It allows us to pursue our mission by responding to the key challenges of modern medicine.
ESG
CSR
Adamed Foundation
Social programmes
Code of Ethics
Responsibility is one of our key values. It is at the core of everything we do and has earned us the trust of patients and the medical community.
Career
Career
Benefits
Development
Locations
Internships and apprenticeships
People are a priority at Adamed, and their passion and dedication has helped us grow into a successful company. Recognising the value of our staff, we are committed to providing excellent work conditions and career opportunities.
Contact

Global English

Popular searches Innovations About Adamed Business Development Adamed worldwide Researches

x

R&D Pilot Plant in Pabianice

Officially opened on 18 April 2018, the R&D Pilot Plant received funding from European Union structural funds. Thanks to the support given by the Ministry of Economic Development, Adamed has been able to implement highly innovative technologies such as Hot Melt Extrusion (HME), bi-layered tablet technology, and fluid bed granulation.

The new plant can manufacture optimisation batches, regulatory pilot batches, as well as batches for clinical studies, including bioequivalence studies. The opening of the new specialised Plant has enabled Adamed to conduct research projects even more effectively by identifying, optimising, and validating critical manufacturing parameters as early as at the development stage.

Equipped with cutting-edge technologies, the R&D Pilot Plant can be used to manufacture valued added products and develop innovative dosage forms to provide patients with high-quality medicinal products offering the desired efficacy and safety profile.